Target intelligence / Profile preview

Serine palmitoyltransferase small subunit B (SPTSSB)

Target
SPTSSB
Molecular classification
Enzyme, Transferase
01

Overview

Serine palmitoyltransferase small subunit B is a protein-coding component of the SPT heterotrimer, which regulates the initial and rate-limiting step of sphingolipid biosynthesis by condensing L-serine and a fatty acyl-CoA to generate long-chain bases, the backbone of sphingolipids. The SPT complex is composed of larger catalytic subunits (SPTLC1 and SPTLC2 or SPTLC3) and a small regulatory subunit, either SPTSSA or SPTSSB. SPTSSB increases the catalytic activity and acyl-CoA chain-length preference of SPT, influencing the composition of sphingolipids and thus membrane structure and cellular signaling. Mutations affecting SPTSSB or its regulation are implicated in hereditary neuropathies and neurodegenerative disease due to aberrant sphingolipid production and axonal degeneration.

Other names
SPTSSBSPTSBSPT small subunit B
02

Mechanism of action

Most potential drugs would act as enzyme inhibitors of SPT; modulation would alter sphingolipid production, affecting cell signaling and membrane properties

03

Biological functions

Sphingolipid biosynthesisLipid metabolismRegulating substrate specificity of SPTModulation of membrane composition
04

Disease associations

Neurodegenerative diseaseHereditary sensory and autonomic neuropathy type 1Hereditary sensory neuropathyMetabolic conditions
05

Safety considerations

Disruption of sphingolipid metabolism can cause serious neurodegenerative symptomsProtein homeostasis impairment, axon degeneration, and membrane structural abnormalities as seen in mouse models
06

Biomarkers

Increased levels of atypical sphingolipids, such as C20 long-chain bases

Beyond the preview

Go deeper on Serine palmitoyltransferase small subunit B (SPTSSB).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serine palmitoyltransferase small subunit B (SPTSSB).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call